WM-1119 |
WM-1119 : Inhibitor of KAT6A
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KAT6A |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
WM-1119 is 1,100-fold and 250-fold more active against KAT6A than against KAT5 or KAT7
In Cell Selectivity Assessment
Selectivity Assessment Description:
No affinity on off-target panel of 159 diverse targets at 1 or 10 µM
Potency Cellular
In Vitro
KAT6A
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b02071
In Vivo Validations
Rat
Dose: 2.9 mg/kg
Route of delivery:
Intravenous
Plasma half life:
7.7 h
Systemic clearance:
21 mL/min/kg
Area Under the Curve::
6.2 μM·h
Volume of Distribution at Steady-State:
0.72 L/kg
DOI Reference: 10.1021/acs.jmedchem.9b02071
Dose: 33 mg/Kg
Route of delivery:
Oral
Plasma half life:
6.4 h
Cmax:
2.9 uM
Tmax:
1.0 h
Area Under the Curve::
13 μM·h
Bioavailability:
18%
Target engagement assay:
HPMC (suspension) (mean ± SD)
DOI Reference: 10.1021/acs.jmedchem.9b02071
Dose: 31 mg/Kg
Route of delivery:
Oral
Plasma half life:
6.0 h
Cmax:
14 uM
Tmax:
1.0 h
Area Under the Curve::
38 μM·h
Bioavailability:
56%
Target engagement assay:
PEG400/Solutol HS-15/water (solution) (mean ± SD)
DOI Reference: 10.1021/acs.jmedchem.9b02071
Negative Control Compounds
WM-2474
Notes: WM-2474: KAT6A IC50 > 50 µM (HAT activity assay (AlphaScreen)); No effect on Fucci MEFs at 10 µM. Clean GPCR scan.
Chemical Information
| Molecular Formula | C18H13F2N3O3S |
| SMILEs | O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1 |
| InChI | InChI=1S/C18H13F2N3O3S/c19-14-10-12(16-6-3-4-8-21-16)9-13(11-14)18(24)22-23-27(25,26)17-7-2-1-5-15(17)20/h1-11,23H,(H,22,24) |
| Molecular weight | 389.06 Da |
| AlogP | 2.6501 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 40 |
References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.